Brusko Todd M, Hulme Maigan A, Myhr Courtney B, Haller Michael J, Atkinson Mark A
Department of Pathology, Immunology and Laboratory Medicine, University of Florida, Gainesville, Florida, USA.
Immunol Invest. 2007;36(5-6):607-28. doi: 10.1080/08820130701790368.
Regulatory T cells (Treg) play a vital role in controlling peripheral immune responses in order to prevent autoimmunity and control inflammation. Altered Treg activities have been associated with the pathogenesis of multiple disorders including autoimmunity, allergy, cancer, and infection with persistent pathogens. As such, a great deal of interest has recently been directed towards developing additional tools and methods to better understand the mechanisms of suppression employed by Treg. The in vitro suppression assay has emerged as a valuable means by which to assess the functional capacity and activity of Treg. In this review, we summarize the merits and limitations of the various in vitro assays that have been utilized to assess Treg activity and present a novel two color proliferation assay that allows simultaneous monitoring of both regulatory and effector T cell activity. As further immunomodulatory therapies are explored, the need for additional methodologies to understand the cellular and molecular mechanisms of immune regulation conferred by Treg will play an increasingly important role.
调节性T细胞(Treg)在控制外周免疫反应以预防自身免疫和控制炎症方面发挥着至关重要的作用。Treg活性的改变与多种疾病的发病机制有关,包括自身免疫、过敏、癌症以及持续性病原体感染。因此,最近人们对开发更多工具和方法以更好地理解Treg所采用的抑制机制产生了浓厚兴趣。体外抑制试验已成为评估Treg功能能力和活性的一种有价值的手段。在本综述中,我们总结了用于评估Treg活性的各种体外试验的优缺点,并提出了一种新型双色增殖试验,该试验能够同时监测调节性T细胞和效应性T细胞的活性。随着进一步探索免疫调节疗法,对于更多方法来理解Treg赋予的免疫调节的细胞和分子机制的需求将发挥越来越重要的作用。